XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102,607,998 | -11.8% | 3,003,747 | -0.6% | 0.76% | +29.5% |
Q2 2023 | $116,349,734 | +7.8% | 3,022,071 | +0.2% | 0.59% | -16.3% |
Q1 2023 | $107,971,916 | -10.1% | 3,016,818 | -1.0% | 0.70% | -26.8% |
Q4 2022 | $120,098,812 | +24.9% | 3,045,874 | +14.4% | 0.96% | +56.4% |
Q3 2022 | $96,124,000 | +24.4% | 2,662,722 | +4.8% | 0.61% | +34.8% |
Q2 2022 | $77,269,000 | +15.4% | 2,540,059 | +16.0% | 0.45% | +50.3% |
Q1 2022 | $66,950,000 | +27.0% | 2,190,059 | +29.7% | 0.30% | +52.5% |
Q4 2021 | $52,734,000 | – | 1,688,044 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |